1. Home
  2. HURA vs UNB Comparison

HURA vs UNB Comparison

Compare HURA & UNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HURA
  • UNB
  • Stock Information
  • Founded
  • HURA 2009
  • UNB 1891
  • Country
  • HURA United States
  • UNB United States
  • Employees
  • HURA N/A
  • UNB N/A
  • Industry
  • HURA
  • UNB Major Banks
  • Sector
  • HURA
  • UNB Finance
  • Exchange
  • HURA Nasdaq
  • UNB Nasdaq
  • Market Cap
  • HURA 131.8M
  • UNB 117.7M
  • IPO Year
  • HURA N/A
  • UNB 1998
  • Fundamental
  • Price
  • HURA $2.12
  • UNB $21.68
  • Analyst Decision
  • HURA Strong Buy
  • UNB
  • Analyst Count
  • HURA 2
  • UNB 0
  • Target Price
  • HURA $11.50
  • UNB N/A
  • AVG Volume (30 Days)
  • HURA 179.3K
  • UNB 11.0K
  • Earning Date
  • HURA 11-14-2025
  • UNB 11-10-2025
  • Dividend Yield
  • HURA N/A
  • UNB 6.64%
  • EPS Growth
  • HURA N/A
  • UNB 27.30
  • EPS
  • HURA N/A
  • UNB 2.47
  • Revenue
  • HURA N/A
  • UNB $52,533,000.00
  • Revenue This Year
  • HURA N/A
  • UNB N/A
  • Revenue Next Year
  • HURA N/A
  • UNB N/A
  • P/E Ratio
  • HURA N/A
  • UNB $9.35
  • Revenue Growth
  • HURA N/A
  • UNB 13.25
  • 52 Week Low
  • HURA $1.80
  • UNB $20.65
  • 52 Week High
  • HURA $7.20
  • UNB $37.70
  • Technical
  • Relative Strength Index (RSI)
  • HURA 32.79
  • UNB 33.66
  • Support Level
  • HURA $2.01
  • UNB $22.60
  • Resistance Level
  • HURA $2.60
  • UNB $23.57
  • Average True Range (ATR)
  • HURA 0.15
  • UNB 0.78
  • MACD
  • HURA -0.04
  • UNB -0.03
  • Stochastic Oscillator
  • HURA 8.84
  • UNB 31.64

About HURA TuHURA Biosciences Inc. Common Stock

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

About UNB Union Bankshares Inc.

Union Bankshares Inc operates as a community bank in the financial services industry. It offers retail and commercial banking services to its customers through its branches, ATMs, telebanking, and internet banking systems. The company provides retail banking services to individuals and commercial banking services to small and medium-sized corporations, partnerships, and sole proprietorships, as well as nonprofit organizations, local municipalities, and school districts within its market area. In addition, it also offers fiduciary and asset management services through its Asset Management Group.

Share on Social Networks: